Does an elevated platelet count increase risk of arterial and venous thrombosis?

The relationship between an elevated platelet count (thrombocytosis) and thrombotic risk is well-documented, particularly in the context of aging and hematological conditions. In older adults, even modest elevations within or just above the normal range can signify a prothrombotic state.

Clinical evidence for thrombotic risk

Data from large prospective cohorts support the association between higher platelet counts and cardiovascular events:

• Arterial and venous events: The Cardiovascular Health Study (n=5,766 adults aged ≥65) found that baseline platelet counts in the highest quintile were significantly associated with increased risks of myocardial infarction, ischemic stroke, and venous thrombosis over 15 years of follow-up.
• All-cause mortality: Several large studies show a U-shaped association between platelet counts and mortality, where counts above the median range (e.g., >300 x 10⁹/L) correlate with significantly higher all-cause mortality rates in older populations.
• Clonal vs. reactive causes: In patients over 60, primary thrombocytosis (e.g., Essential Thrombocythemia) carries a high risk of thrombosis, necessitating preventive treatment. Conversely, reactive thrombocytosis—driven by inflammation, iron deficiency, or infection—requires treating the underlying cause, as the thrombotic risk is tied to the primary illness.

Mechanistic explanations

Aging and biological mutations alter platelet behavior, increasing the risk of clot formation:

• Platelet hyperreactivity: Aging is associated with enhanced platelet activation markers (e.g., P-selectin expression), increased production of thromboxane A2, and more frequent platelet-leukocyte aggregates, creating a systemic prothrombotic milieu.
• JAK2 mutations: In clonal thrombocytosis, mutations like JAK2V617F increase platelet reactivity and interaction with the vessel wall, drastically raising the likelihood of arterial and venous events.
• Paradoxical bleeding: At extreme levels (typically >1,000–1,500 x 10⁹/L), thrombocytosis can cause acquired von Willebrand Syndrome (aVWS) due to the depletion of high-molecular-weight von Willebrand factor multimers, leading to a risk of bleeding despite the high count.

Bottom line

Elevated platelet count is a robust indicator of increased risk for both arterial and venous thrombosis in older adults. For a 73-year-old female, thrombocytosis warrants careful evaluation to distinguish between reactive and clonal causes, as the underlying driver and the presence of age-related hyperreactivity significantly influence clinical management and thrombotic risk.